HLA gene
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (47)
Papers in which this entity is mentioned.
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Robust and accurate Bayesian inference of genome-wide genealogies for hundreds of genomes. (2025)
- Chromosomal instability as a driver of cancer progression. (2025)
- Functional analysis of cancer-associated germline risk variants. (2025)
- Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
- Principles and methods for transferring polygenic risk scores across global populations. (2024)
- Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. (2023)
- Most non-canonical proteins uniquely populate the proteome or immunopeptidome. (2021)
- Nanopore sequencing technology, bioinformatics and applications. (2021)
- Rapid genotype imputation from sequence with reference panels. (2021)
- Genotypes of informative loci from 1000 Genomes data allude evolution and mixing of human populations. (2021)
- Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. (2021)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- MHCAttnNet: predicting MHC-peptide bindings for MHC alleles classes I and II using an attention-based deep neural model. (2020)
- Immuno-genomic landscape of osteosarcoma. (2020)
- Reciprocal monoallelic expression of ASAR lncRNA genes controls replication timing of human chromosome 6. (2020)
- Machine Learning-Enhanced T Cell Neoepitope Discovery for Immunotherapy Design. (2019)
- HLA-VBSeq v2: improved HLA calling accuracy with full-length Japanese class-I panel. (2019)
- Rare variant phasing using paired tumor:normal sequence data. (2019)
- Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- HLA*LA-HLA typing from linearly projected graph alignments. (2019)
- Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
- Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. (2018)
- Immune diversity sheds light on missing variation in worldwide genetic diversity panels. (2018)
- The Immune Landscape of Cancer. (2018)
- Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
- Fast and accurate HLA typing from short-read next-generation sequence data with xHLA. (2017)
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. (2017)
- The fractured landscape of RNA-seq alignment: The default in our STARs (2017)
- Fast and Accurate Genomic Analyses using Genome Graphs (2017)
- High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference Graphs. (2016)
- Detecting Genomic Signatures of Natural Selection with Principal Component Analysis: Application to the 1000 Genomes Data. (2016)
- The IPD and IMGT/HLA database: allele variant databases. (2015)
- HLAreporter: a tool for HLA typing from next generation sequencing data. (2015)
- Profiling tissue-resident T cell repertoires by RNA sequencing. (2015)
- HLA-VBSeq: accurate HLA typing at full resolution from whole-genome sequencing data. (2015)
- Transcriptome sequencing of a large human family identifies the impact of rare noncoding variants. (2014)
- Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads. (2014)
- OptiType: precision HLA typing from next-generation sequencing data. (2014)
- Cancer genome landscapes. (2013)
- HLA typing from 1000 genomes whole genome and whole exome illumina data. (2013)
- Properties of MHC class I presented peptides that enhance immunogenicity. (2013)
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
- HLA typing from RNA-Seq sequence reads. (2012)
- The HLA system: genetics, immunology, clinical testing, and clinical implications. (2007)
- A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. (2006)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| hla | gene | 56 | 254 |
| hla genes | gene | 12 | 16 |
| human leukocyte antigen | gene | 3 | 3 |
| hla types | gene | — | — |
| human lymphocyte antigen | gene | — | — |